Strategic Partnerships Blood Cancer United has a track record of forging high-profile collaborations with foundations, pharmaceutical partners, and research institutions (e.g., Royalty Pharma, Rising Tide Foundation, WVU Cancer Institute). This indicates strong alliance-building potential for joint fundraising, grant programs, or co-funded research initiatives.

Funding Levers With an annual commitment stream including recent $4M financing and a long-standing donor network (Harry T. Mangurian, Jr. Foundation; total support over 15 years), there are opportunities to engage sponsors for multi-year campaigns, program sponsorships, and targeted fundraising tiers aligned to blood cancer research milestones.

Impact Transparency Leadership is prioritizing accountability and measurement (developing annual progress reports toward the 2040 goal). This creates a selling point for data-driven grant programs, impact dashboards for corporate sponsors, and consultancy services around outcomes reporting.

Technology Enablement The tech stack includes analytics, CRM, and data platforms (Power BI, Snowflake, Microsoft Dynamics, SAS, Drupal). There is potential to offer technology modernization, donor analytics, and digital engagement services to improve fundraising efficiency and supporter experiences.

Community and Outreach Active public-facing initiatives (Light the Night partnerships, caregiver support, patient information services) signal opportunities to upsell education platforms, caregiver programs, and sponsored patient assistance tools to employers, health systems, and local communities.